Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03642236
Status:
UNKNOWN
Last Update Posted:
2018-08-22
First Post:
2018-08-20
Brief Title:
Combination of BTK Inhibitor Overcomes Drug-resistance in RefractoryRelapsed FLT3 Mutant AML
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Organization Data
Organization:
Nanfang Hospital Southern Medical University
Class:
OTHER
Study ID:
BTKi in FLT3 mutant AML
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanfang Hospital Southern Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
yuguopan
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanfang Hospital Southern Medical University
Old Name:
None
Old Organization:
None